{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:19:00Z","timestamp":1747156740289,"version":"3.40.5"},"reference-count":18,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.canrad.2024.09.004","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T18:49:48Z","timestamp":1729277388000},"page":"519-522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u00c9tudes qui changent les pratiques en oncoradioth\u00e9rapie digestive"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2133-6454","authenticated-orcid":false,"given":"Anouchka","family":"Modesto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosine","family":"Guimbaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Vendrely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2024.09.004_bib0095","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa2032125","article-title":"Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer","volume":"384","author":"Kelly","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2024.09.004_bib0100","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"Al-Batran","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2024.09.004_bib0105","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"Van Hagen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2024.09.004_bib0110","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.ijrobp.2021.07.045","article-title":"Exclusive chemoradiotherapy with or without radiation dose escalation in esophageal cancer: multicenter phase 2\/3\u00a0randomized trial CONCORDE (PRODIGE-26)","volume":"111","author":"Cr\u00e9hange","year":"2021","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2024.09.004_bib0115","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1200\/JCO.20.03697","article-title":"Randomized study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer (ARTDECO study)","volume":"39","author":"Hulshof","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2024.09.004_bib0120","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1470-2045(14)70028-2","article-title":"Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5\/ACCORD17): final results of a randomised, phase 2\/3\u00a0trial","volume":"15","author":"Conroy","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2024.09.004_bib0125","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1200\/JCO.2024.42.16_suppl.4005","article-title":"NRG Oncology\/RTOG 0848: results after adjuvant chemotherapy with or without chemoradiation for patients with resected periampullary pancreatic adenocarcinoma (PA)","volume":"42","author":"Abrams","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2024.09.004_bib0130","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with folfirinox and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3\u00a0trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2024.09.004_bib0135","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.annonc.2024.06.019","article-title":"Total neoadjuvant therapy with mfolfirinox versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23\u00a0trial","volume":"35","author":"Conroy","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2024.09.004_bib0140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3\u00a0trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2024.09.004_bib0145","doi-asserted-by":"crossref","first-page":"e766","DOI":"10.1097\/SLA.0000000000005799","article-title":"Locoregional failure during and after short-course radiotherapy followed by chemotherapy and surgery compared with long-course chemoradiotherapy and surgery: a 5-year follow-up of the RAPIDO trial","volume":"278","author":"Dijkstra","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.canrad.2024.09.004_bib0150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.radonc.2022.04.013","article-title":"Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer\u00a0\u2013\u00a0the RAPIDO trial","volume":"171","author":"Dijkstra","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2024.09.004_bib0155","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejca.2022.11.020","article-title":"Comparison of short course radiotherapy with chemoradiotherapy for locally advanced rectal cancers in the elderly: a multicentre, randomised, non-blinded, phase 3\u00a0trial","volume":"180","author":"Fran\u00e7ois","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2024.09.004_bib0160","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1200\/JCO.23.01208","article-title":"Long-term results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: the randomized phase II OPRA trial","volume":"42","author":"Verheij","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2024.09.004_bib0165","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S2468-1253(22)00392-2","article-title":"Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3\u00a0rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial","volume":"8","author":"G\u00e9rard","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.canrad.2024.09.004_bib0170","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.3390\/cancers14153665","article-title":"MORPHEUS phase II\u2013III study: a pre-planned interim safety analysis and preliminary results","volume":"14","author":"Garant","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.canrad.2024.09.004_bib0175","doi-asserted-by":"crossref","first-page":"LBA3512","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA3512","article-title":"Durable complete responses to PD-1\u00a0blockade alone in mismatch repair deficient locally advanced rectal cancer","volume":"42","author":"Cercek","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2024.09.004_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.dld.2024.06.022","article-title":"Chemoradiotherapy versus radiotherapy alone in the management of early-stage anal squamous cell carcinoma: a comparative analysis of the French cohort FFCD-ANABASE","author":"Buchalet","year":"2024","journal-title":"Dig Liver Dis"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321824001513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321824001513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T16:19:06Z","timestamp":1730391546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321824001513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":18,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1278321824001513"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2024.09.004","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00c9tudes qui changent les pratiques en oncoradioth\u00e9rapie digestive","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2024.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO).","name":"copyright","label":"Copyright"}]}}